or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
pharmaceutics PhD Projects, Programmes & Scholarships
We have 26 pharmaceutics PhD Projects, Programmes & Scholarships
A proliposomal strategy for enhancing solubility and absorption of drugs delivered from controlled release vaginal ring devices
Controlled release vaginal rings are used for long-term administration of drugs to the human vagina. Currently, eight ring devices have reached market, mostly focused on estrogen replacement therapy, hormonal contraception, and HIV prevention. Read more
Ultra-long-acting microneedles for biologics delivery
This project aims to develop transdermal microneedle formulations for delivering biologic drugs over several weeks or months. Biologics (e.g. Read more
Microneedle biosensors for rapid and painless disease diagnosis
This project aims to develop rapid disease diagnostics based on transdermal microneedle biosensors. Disease diagnosis often relies on invasive tissue sampling techniques, such as blood sampling or skin biopsies, in order to extract biomarkers for analysis. Read more
Targeting amino-acid transporters for treatment of cancer and neurological disorders
Metabolism is an important biological process that generate energy for cellular functioning across the body. Brain particularly requires a large amount of energy to perform its complex functions. Read more
Quantifying solute-solvent interactions for crystallization design
Most industrial crystallisation processes follow a ‘wet’ chemistry approach, i.e. they involve one or more solvents, but the outcome of a crystallization is not yet possible to predict. Read more
Last chance to apply
(BBSRC NWD) Cryopreservation of Next Generation 3D Bioprinted Tissues
Bioprinting comprises a range of additive manufacturing technologies used in the field of Tissue Engineering and Regenerative Medicine (TE&RM) to shape cells and biomaterials into 3D biological constructs capable of mimicking the structural and functional organization of human tissues and organs. Read more
Last chance to apply
NanoHacker – Engineering Nanomedicines to Hack and Modulate the Immune System
This project is one of a number that are in competition for funding from the University of Bath URSA competition, for entry in September 2025. Read more
Development of Multi-Drug Sutures using Deep Eutectic Reactive Technology for the Prevention of Surgical Site Infections
Surgical site infections (SSIs) cause severe problems and remain a major cause of postoperative mortality, particularly at incision sites that are considered ‘dirty-contaminated’ according to the CDC Surgical Wound Classification (SWC Class IV). Read more
3D-printing of implantable devices for sustained drug delivery
The demand for customised medical devices is driving growth in the 3D-printing medical device market, valued at US$3.76 billion and growing at 14% annually. Read more
The Development of Implantable Anti-tumour Devices for Enhanced Efficacy of Repurposed Drugs Using Advanced Manufacturing
Drug repurposing or repositioning, which investigates new indications for approved drugs, has always been a core approach in drug development, with approximately 30-40% of new drugs and biologics approved by the US FDA between 2007 and 2009 being repurposed or repositioned products (DOI. Read more
The Development of a Robust Risk-Based Approach to the use of Hot Melt Extrusion for the Manufacture of Amorphous Solid Dispersions
This project builds upon the extensive experience within the Pharmaceutical Engineering team at the School of Pharmacy to develop a risk-based approach to evaluate the suitability of hot melt extrusion as a manufacturing technique for amorphous solid dispersions. . Read more
3D-printing of implantable devices for sustained drug delivery
The demand for customised medical devices is driving growth in the 3D-printing medical device market, valued at US$3.76 billion and growing at 14% annually. Read more
Developing and characterising novel targeted nanocomposites serving as adjuvants to existing standard-of-care cancer treatments
One in two cancer patients will receive radiotherapy as part of their standard-of-care treatment. For patients with a localised cancer diagnosis effective radiotherapy represents the best chance for a curative outcome but is not without risk. Read more
Microfluidic Encapsulation of biologics into Nanomedicines
Progress in drug design has led to the development of new peptides, proteins, and drug molecules. However, the limited ability to deliver selectively these molecules at well-defined dosing regimens and without invoking drug-resistance remains a significant challenge. Read more
Design and Evaluation of an eye-on-a-chip Microfluidic Device
With the increasing prevalence of debilitating eye diseases such as age-related macular degeneration, glaucoma, and dry-eye syndromes, there is a pressing need for the development of novel therapeutic strategies. Read more
- 1
- 2